Nytt om UBs kjemiressurser (Reaxys og SciFinder) / News about the Chemistry resources at the library.

Information in English below
---------------------------------------

Universitetsbiblioteket beklager å måtte informere om at UiT ikke lengre tilbyr tilgang til kjemidatabasen SciFinder.

Vi har istedet inngått en avtale med Reaxys. Se nedenfor for mer informasjon om tjenesten på engelsk.

For å bruke Reaxys må dere enten befinne dere på UiT eller bruke proxy (likt som for artikkeltilgang), lenke kan man finne ved å søke på Reaxys i Oria (https://www-reaxys-com.mime.uit.no/#/search/quick). Dere vil ikke finne UiT i listen over institusjoner i på Reaxys sitt innloggingsalternativ.

Dersom dere ønsker å bruke retrosynteseverktøyet eller lagre søk må dere opprette en Elsevier konto.

For å hjelpe oss med å komme i gang, vil Reaxys holde en demonstrasjon og besvare spørsmål, på mandag 6. mars kl 14.15. Dersom man kun ønsker å komme for å stille spørsmål kan man logge på kl 15.00. Logg på via Zoom-lenke på arrangementet her: https://uit.no/tavla/artikkel/803844/reaxys_on-boarding_demo

Vi håper at Reaxys vil oppfylle behovene dere har og vi tar gjerne imot tilbakemeldinger på tjenesten. Jeg vil også være behjelpelig med å få dere i gang, ikke nøl med å ta kontakt om dere trenger hjelp eller har spørsmål.

Mvh

Aili Sarre
Fagreferent for kjemi, farmasi og biokjemi

--------------------

The University Library regrets to inform you that UiT no longer offers access to the chemistry database SciFinder. Instead, we have entered into an agreement with Reaxys. Please see below for more information about Reaxys.

To use Reaxys, you must either be at UiT or use a proxy (same way you access articles). The proxy can be found by searching for Reaxys in Oria (https://www-reaxys-com.mime.uit.no/#/search/quick). You will not find UiT in the list of institutions in the login options of Reaxys.

Note, that if you wish to use the Retrosynthesis tool or save your searches, you must create an Elsevier account.

Reaxys will hold a demonstration to help us get started on Monday, March 6th at 14:15. If you only want to come to ask questions, you can log on at 15:00. You may find the zoom-link here: https://uit.no/tavla/artikkel/803844/reaxys_on-boarding_demo

We hope that Reaxys will meet your needs, and we are happy to receive any feedback you might have. Feel free to contact me if you need help getting started or have any questions.

Best,
Aili Sarre
Subject Librarian for chemistry, pharmacology and biochemistry.

Information about Reaxys

Designed by chemists, Reaxys Academic Edition is a unique web-based chemistry tool, consisting of deeply excerpted compounds and related properties, reaction and synthesis information as well as bibliographic data, navigated and displayed via a user-friendly interface.

Improve how to search and filter for chemical substances, properties and reactions with Reaxys Academic Edition! You will: design experiments more successfully based on the most recent research and patent literature, study chemical compounds, biological targets and substance-target interactions, investigate published and predicted synthetic routes and carefully plan the budget needed for your research projects.

Reaxys Academic Edition provides access to: >257 million organic, inorganic and organometallic substances, including data on natural products with their species derivation; >60 million chemical reactions; >500 million published experimental facts, including substance property, spectral and reaction data; >101 million documents from a collection of over 16,000 chemistry-related periodicals from multiple publishers; >36 million patents from 105 patent offices with titles, abstracts and claims translated to English; 6 indexing sources for a cross-disciplinary view of chemistry.

Reaxys Academic Edition incorporates all the existing content of classic Reaxys. In addition, Reaxys Academic Edition supports research and teaching goals across all Chemistry disciplines with content and functionalities from 2 additional modules:

1) Reaxys Target & Bioactivity insights, the world’s largest medicinal chemistry database, containing in vivo, in vitro, efficacy, drug pharmacokinetics and safety/toxicity data to achieve rapid hit identification and lead optimization:

44 million bioactivity data points 37k biological targets 21k Cell lines from 56k species 8.2 million unique substances with bioactivity 146k medicinal chemistry patents 603k medicinal chemistry articles

2) Reaxys Predictive Retrosynthesis: creates robust predictions and feasible synthetic routes that leverages deep learning technology and reaction data from Reaxys to support synthesis planning of known and novel small organic molecules (“Target molecules”), as it combines three different neural networks together with Monte Carlo tree search (3N-MCTS) to perform chemical synthesis planning. 3N-MCTS is a deep neural network trained on known working reactions and on artificially generated non-working reactions, based on ~400,000 reaction transformation rules extracted from ~15 million single-step reactions from the Reaxys chemistry database.

More information: https://www.elsevier.com/solutions/reaxys/higher-education/chemistry-research-in-academia